On May 27th and 28th, the AFFIRMO Consortium held a key project meeting at the ANMCO National Headquarters, located in the heart of Florence. This two-day event focused on the project's core objectives, particularly the advancement of healthcare for older patients affected by atrial fibrillation (AF) and multimorbidity.

The focus of the debate was AFFIRMO’s core mission: addressing cardiovascular pathologies and related chronic conditions in older populations, with the goal of improving patients’ quality of life during and after treatment. In this context, the widespread issue of polypharmacy—common among millions of older patients—was recognised as a significant challenge to be addressed.

The first day featured presentations on all nine AFFIRMO Work Plans (WPs), highlighting the main outcomes and achievements to date. These presentations showcased the project's contributions to improving care pathways and clinical outcomes for patients with AF. The day concluded with a hybrid-format General Assembly, where key findings and strategic directions were discussed collectively by the consortium members.

Furthermore, the second day marked the launch of cluster activities within the TARGET and ARISTOTELES initiatives, coordinated respectively by Dr Sandra Ortega-Martorell and Prof. Giuseppe Boriani. In this subsequent phase, participants shared their primary goals and outlined action plans for the coming six months, laying the groundwork for upcoming healthcare studies.

The meeting provided a valuable opportunity to reflect on the tangible results achieved through AFFIRMO’s research and to assess its impact on healthcare practices related to cardiovascular diseases. Events like this are considered crucial to the AFFIRMO project, offering important moments for growth, collaboration, and the advancement of scientific research.

We look forward to future updates from the project members and the experts collaborating with AFFIRMO, as well as the continued progress it will bring to atrial fibrillation research and care.